Rice alum Louis Brus awarded Nobel Prize in chemistry
Rice alumnus Louis Brus (’65) has been awarded the Nobel Prize in Chemistry alongside Moungi Bawendi and Alexei Ekimov for the “discovery and development of quantum dots.”
The 2026 Rice Business Plan Competition announced today the 42 startups invited to compete for more than $1 million in prizes April 9-11 at Rice Unive...
The Jesse H. Jones Graduate School of Business at Rice has been recognized among top graduate programs in the Financial Times global business school r...
“Let’s begin with a very simple premise — simple but extremely important: Sound policy depends on sound data,” said David Satterfield, director of Ric...
The Texas-France Space hub's first annual Houston Space Galette, held Feb. 12, fostered dialogue within the Houston space community. ...
Rice University’s Virani Undergraduate School of Business is expanding its undergraduate business major with the launch of a new marketing concentrati...
a spirit of conversation defined the two-day conference organized by Rice’s School of Humanities and Arts faculty Jacqueline Couti and Caroline Fache ...
When the Rice360 Institute for Global Health Technologies launched the first design studios in partner universities across Africa during Phase 1 of th...
The Liu Idea Lab for Innovation and Entrepreneurship (Lilie) is thrilled to introduce the latest Rice Innovation Fellows 2026 cohort, a dynamic group ...
Rice Biotech Launch Pad introduces external advisory board
Rice University today announced its external advisory board for the Rice Biotech Launch Pad, the new accelerator focused on expediting the translation of the university’s health and medical technology discoveries into cures.
Two Rice bioengineers win NIH Director’s New Innovator awards
Rice bioengineers Jerzy Szablowski and Julea Vlassakis received the NIH Director’s New Innovator Award for their respective research projects. Szablowski’s work seeks to develop a noninvasive method of mapping gene expression, while Vlassakis is studying complex, single-cell level processes and interactions in pediatric bone cancer.
Rice stymied East Carolina’s last three drives with fourth down stops to give the Owls a win in its inaugural home game in the American Athletic Conference, 24-17 at Rice Stadium on Sept. 30.
Houston residents willing to pay more for city parks, Rice Kinder Institute survey shows
Despite having one of the largest urban park systems in the country and one of the highest levels of philanthropic support of parks, Houston falls behind other major cities in funding them — and a majority of residents say they are willing to spend more to elevate the city’s investment, a new study by the Kinder Institute for Urban Research at Rice University has found.
NSF backs Rice processor design, chip security research
Rice computer scientists have won two grants from the National Science Foundation to explore new information processing technologies and applications that combine co-designed hardware and software to allow for more effective and efficient data stream analysis using pattern matching.
Rice joins nationwide effort to make financial aid more transparent
Rice University is one of more than 360 colleges in the U.S. committed to making financial aid offers more transparent.
It's easier to get valuable metals from battery waste if you ‘flash’ it
A battery recycling process developed by Rice scientists can retrieve valuable metals from mixed cathode and anode waste with a yield exceeding 98% in less time than normal using low-concentration acid, reducing both the cost and negative environmental impact.
NIH funds new Baylor/Rice genome editing testing center
A five-year, $3.9 million grant from the National Institutes of Health will help establish a joint Baylor College of Medicine/Rice University center to support the development and testing of new genome editing technologies.
Feds fund $45M Rice-led research that could slash US cancer deaths by 50%
The Advanced Research Projects Agency for Health has awarded a Rice-led team $45 million to rapidly develop an implant with sense-and-respond technology that could slash U.S. cancer-related deaths by more than 50%.